Sounak Gupta, M.B.B.S., Ph.D., explains how Mayo Clinic Laboratories' urologic panels efficiently inform prognosis and individualized cancer treatment. The carefully curated panels fill the void between single gene assays and large NGS panels.

(00:32)
 Could you provide our listeners with a little bit about yourself and your background, please?

(01:35)
 Could you give us a brief overview of the newly developed urologic assays?

(03:51)
 Can you talk a little bit more about what patients should have this testing?

(07:24)
 Can you talk in more detail about the MayoComplete bladder and prostate panel?

(11:33)
 How are these results used in patient care?

(16:10)
 Is there anything else you would like to add?